By Adam Bonislawski

Among the many challenges facing mass spec-based proteomics as it tries to move out of the laboratory and into the clinic, the need for higher-throughput assays dominated discussion this week at the Association for Mass Spectrometry's third annual Applications to the Clinical Lab meeting in San Diego.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.